Dose-dependent effects of nicotine on proliferation and differentiation of human bone marrow stromal cells and the antagonistic action of vitamin C

• Published in: Journal of cellular biochemistry 2013-08, Vol.114 (8), p.1720-1728
• Main Authors: Shen, Yue, Liu, Hai-xiao, Ying, Xiao-zhou, Yang, Shi-zhou, Nie, Peng-fei, Cheng, Shao-wen, Wang, Wei, Cheng, Xiao-jie, Peng, Lei, Xu, Hua-zi
• Format: Article
• Language: English
• Subjects: Adult; Aged; Antioxidants - pharmacology; Ascorbic Acid - antagonists & inhibitors; Ascorbic Acid - pharmacology; Bone Marrow Cells - cytology; Bone Marrow Cells - metabolism; Bone Morphogenetic Protein 2 - biosynthesis; Cell Differentiation - drug effects; Cell Proliferation - drug effects; Cells, Cultured; Dose-Response Relationship, Drug; Drug Antagonism; Female; Ganglionic Stimulants - antagonists & inhibitors; Ganglionic Stimulants - pharmacology; Gene Expression Regulation - drug effects; HUMAN BMSCs; Humans; Male; Middle Aged; NICOTINE; Nicotine - antagonists & inhibitors; Nicotine - pharmacology; Osteogenesis - drug effects; OSTEOGENIC DIFFERENTIATION; PROLIFERATION; Stromal Cells - cytology; Stromal Cells - metabolism; VITAMIN C
• ISSN: 0730-2312; 1097-4644
• DOI: 10.1002/jcb.24512

A range of biological and molecular effects caused by nicotine are considered to effect bone metabolism. Vitamin C functions as a biological antioxidant. This study was to evaluate the in vitro effects of nicotine on human bone marrow stromal cells and whether Vitamin C supplementation show the antagonism action to high concentration nicotine. We used CCK‐8, alkaline phosphatase (ALP) activity assay, Von Kossa staining, real‐time polymerase chain reaction and Western Blot to evaluate the proliferation and osteogenic differentiation. The results indicated that the proliferation of BMSCs increased at the concentration of 50, 100 ng/ml, got inhibited at 1,000 ng/ml. When Vitamin C was added, the OD for proliferation increased. For ALP staining, we found that BMSCs treated with 50 and 100 ng/ml nicotine showed a higher activity compared with the control, and decreased at the 1,000 ng/ml. Bone morphogenetic protein‐2 (BMP‐2) expression and the calcium depositions decreased at 100 and 1,000 ng/ml nicotine, while the addition of Vitamin C reversed the down regulation. By real‐time PCR, we detected that the mRNA expression of collagen type I (COL‐I) and ALP were also increased in 50 and 100 ng/ml nicotine groups (P